{"id":499424,"date":"2021-05-27T08:34:17","date_gmt":"2021-05-27T12:34:17","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/oncosec-to-present-at-the-raymond-james-human-health-innovation-conference\/"},"modified":"2021-05-27T08:34:17","modified_gmt":"2021-05-27T12:34:17","slug":"oncosec-to-present-at-the-raymond-james-human-health-innovation-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/oncosec-to-present-at-the-raymond-james-human-health-innovation-conference\/","title":{"rendered":"OncoSec to Present at the Raymond James Human Health Innovation Conference"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"xn-location\">PENNINGTON, N.J.<\/span> and <span class=\"xn-location\">SAN DIEGO<\/span>, <span class=\"xn-chron\">May 27, 2021<\/span> \/PRNewswire\/ &#8212;\u00a0OncoSec Medical Incorporated (NASDAQ:ONCS) (the &#8220;Company&#8221; or &#8220;OncoSec&#8221;) today announced that management will present a company overview at the Raymond James Human Health Innovation Conference being held virtually <span class=\"xn-chron\">Monday, June 21<\/span><sup>st<\/sup> \u2013 <span class=\"xn-chron\">Wednesday, June 23<\/span><sup>rd<\/sup>, 2021. <\/p>\n<p>\n        <b>Raymond James Human Health Innovation Virtual Conference<br \/><\/b>Date: <span class=\"xn-chron\">Monday, June 21<\/span><sup>st<\/sup>\u00a0\u00a0<br \/>Time: <span class=\"xn-chron\">12:00pm ET<\/span><\/p>\n<p>For those not attending the conference, a replay of the presentation will be available for 90 days in the &#8220;Events &amp; Presentations&#8221; section of OncoSec&#8217;s website at <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3177531-1&amp;h=3210109172&amp;u=https%3A%2F%2Fir.oncosec.com%2Fevents-presentations&amp;a=https%3A%2F%2Fir.oncosec.com%2Fevents-presentations\" rel=\"nofollow noopener\">https:\/\/ir.oncosec.com\/events-presentations<\/a>.\u00a0\u00a0 <\/p>\n<p>\n        <b>About OncoSec Medical Incorporated<br \/><\/b>OncoSec Medical Incorporated (the &#8220;Company,&#8221; &#8220;OncoSec,&#8221; &#8220;we&#8221; or &#8220;our&#8221;) is a biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body&#8217;s immune system to target and attack cancer. OncoSec&#8217;s lead immunotherapy investigational product candidate \u2013 TAVO\u2122 (tavokinogene telseplasmid) \u2013 enables the intratumoral delivery of DNA-based interleukin-12 (IL-12), a naturally occurring protein with immune-stimulating functions. The technology, which employs electroporation, is designed to produce a controlled, localized expression of IL-12 in the tumor microenvironment, enabling the immune system to target and attack tumors throughout the body. OncoSec has built a deep and diverse clinical pipeline utilizing TAVO\u2122 as a potential treatment for multiple cancer indications either as a monotherapy or in combination with leading checkpoint inhibitors; with the latter potentially enabling OncoSec to address a great unmet medical need in oncology: anti-PD-1 non-responders. Results from recently completed clinical studies of TAVO\u2122 have demonstrated a local immune response, and subsequently, a systemic effect as either a monotherapy or combination treatment approach along with an acceptable safety profile, warranting further development. In addition to TAVO\u2122, OncoSec is identifying and developing new DNA-encoded therapeutic candidates and tumor indications for use with its new Visceral Lesion Applicator (VLA), to target deep visceral lesions, such as liver, lung or pancreatic lesions. For more information, please visit\u00a0<a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3177531-1&amp;h=3857983815&amp;u=http%3A%2F%2Fwww.oncosec.com%2F&amp;a=www.oncosec.com\" rel=\"nofollow noopener\">www.oncosec.com<\/a>.<\/p>\n<p>TAVO\u2122 is a trademark of OncoSec Medical Incorporated.<\/p>\n<p>\n        <b>Company Contact<br \/><\/b><br \/>\n        <span class=\"xn-person\">Brian Leuthner<\/span><br \/>\n        <br \/>Chief Operating Officer<br \/><a target=\"_blank\" href=\"mailto:investors@oncosec.com\" rel=\"nofollow noopener\">investors@oncosec.com<\/a><\/p>\n<p>\n        <b>Media Contact<br \/><\/b><br \/>\n        <span class=\"xn-person\">Patrick Bursey<\/span><br \/>\n        <br \/>LifeSci Communications<br \/>+1-646-970-4688<br \/><a target=\"_blank\" href=\"mailto:pbursey@lifescicomms.com\" rel=\"nofollow noopener\">pbursey@lifescicomms.com<\/a><\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder8836\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/686236\/oncosec_logo_Logo.html\" target=\"_blank\" rel=\"nofollow noopener\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/686236\/oncosec_logo_Logo.jpg\" title=\"OncoSec Medical Incorporated logo (PRNewsfoto\/OncoSec Medical Incorporated)\" alt=\"OncoSec Medical Incorporated logo (PRNewsfoto\/OncoSec Medical Incorporated)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>\u00a0<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder0\"><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=LA91877&amp;sd=2021-05-27\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"http:\/\/www.prnewswire.com\/news-releases\/oncosec-to-present-at-the-raymond-james-human-health-innovation-conference-301300655.html\">http:\/\/www.prnewswire.com\/news-releases\/oncosec-to-present-at-the-raymond-james-human-health-innovation-conference-301300655.html<\/a><\/p>\n<p>SOURCE  OncoSec Medical Incorporated<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=LA91877&amp;Transmission_Id=202105270830PR_NEWS_USPR_____LA91877&amp;DateId=20210527\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire PENNINGTON, N.J. and SAN DIEGO, May 27, 2021 \/PRNewswire\/ &#8212;\u00a0OncoSec Medical Incorporated (NASDAQ:ONCS) (the &#8220;Company&#8221; or &#8220;OncoSec&#8221;) today announced that management will present a company overview at the Raymond James Human Health Innovation Conference being held virtually Monday, June 21st \u2013 Wednesday, June 23rd, 2021. Raymond James Human Health Innovation Virtual ConferenceDate: Monday, June 21st\u00a0\u00a0Time: 12:00pm ET For those not attending the conference, a replay of the presentation will be available for 90 days in the &#8220;Events &amp; Presentations&#8221; section of OncoSec&#8217;s website at https:\/\/ir.oncosec.com\/events-presentations.\u00a0\u00a0 About OncoSec Medical IncorporatedOncoSec Medical Incorporated (the &#8220;Company,&#8221; &#8220;OncoSec,&#8221; &#8220;we&#8221; or &#8220;our&#8221;) is a biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body&#8217;s immune system to target and attack cancer. &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/oncosec-to-present-at-the-raymond-james-human-health-innovation-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;OncoSec to Present at the Raymond James Human Health Innovation Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-499424","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>OncoSec to Present at the Raymond James Human Health Innovation Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/oncosec-to-present-at-the-raymond-james-human-health-innovation-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"OncoSec to Present at the Raymond James Human Health Innovation Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire PENNINGTON, N.J. and SAN DIEGO, May 27, 2021 \/PRNewswire\/ &#8212;\u00a0OncoSec Medical Incorporated (NASDAQ:ONCS) (the &#8220;Company&#8221; or &#8220;OncoSec&#8221;) today announced that management will present a company overview at the Raymond James Human Health Innovation Conference being held virtually Monday, June 21st \u2013 Wednesday, June 23rd, 2021. Raymond James Human Health Innovation Virtual ConferenceDate: Monday, June 21st\u00a0\u00a0Time: 12:00pm ET For those not attending the conference, a replay of the presentation will be available for 90 days in the &#8220;Events &amp; Presentations&#8221; section of OncoSec&#8217;s website at https:\/\/ir.oncosec.com\/events-presentations.\u00a0\u00a0 About OncoSec Medical IncorporatedOncoSec Medical Incorporated (the &#8220;Company,&#8221; &#8220;OncoSec,&#8221; &#8220;we&#8221; or &#8220;our&#8221;) is a biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body&#8217;s immune system to target and attack cancer. &hellip; Continue reading &quot;OncoSec to Present at the Raymond James Human Health Innovation Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/oncosec-to-present-at-the-raymond-james-human-health-innovation-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-05-27T12:34:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/686236\/oncosec_logo_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncosec-to-present-at-the-raymond-james-human-health-innovation-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncosec-to-present-at-the-raymond-james-human-health-innovation-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"OncoSec to Present at the Raymond James Human Health Innovation Conference\",\"datePublished\":\"2021-05-27T12:34:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncosec-to-present-at-the-raymond-james-human-health-innovation-conference\\\/\"},\"wordCount\":369,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncosec-to-present-at-the-raymond-james-human-health-innovation-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/686236\\\/oncosec_logo_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncosec-to-present-at-the-raymond-james-human-health-innovation-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncosec-to-present-at-the-raymond-james-human-health-innovation-conference\\\/\",\"name\":\"OncoSec to Present at the Raymond James Human Health Innovation Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncosec-to-present-at-the-raymond-james-human-health-innovation-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncosec-to-present-at-the-raymond-james-human-health-innovation-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/686236\\\/oncosec_logo_Logo.jpg\",\"datePublished\":\"2021-05-27T12:34:17+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncosec-to-present-at-the-raymond-james-human-health-innovation-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncosec-to-present-at-the-raymond-james-human-health-innovation-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncosec-to-present-at-the-raymond-james-human-health-innovation-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/686236\\\/oncosec_logo_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/686236\\\/oncosec_logo_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncosec-to-present-at-the-raymond-james-human-health-innovation-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"OncoSec to Present at the Raymond James Human Health Innovation Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"OncoSec to Present at the Raymond James Human Health Innovation Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/oncosec-to-present-at-the-raymond-james-human-health-innovation-conference\/","og_locale":"en_US","og_type":"article","og_title":"OncoSec to Present at the Raymond James Human Health Innovation Conference - Market Newsdesk","og_description":"PR Newswire PENNINGTON, N.J. and SAN DIEGO, May 27, 2021 \/PRNewswire\/ &#8212;\u00a0OncoSec Medical Incorporated (NASDAQ:ONCS) (the &#8220;Company&#8221; or &#8220;OncoSec&#8221;) today announced that management will present a company overview at the Raymond James Human Health Innovation Conference being held virtually Monday, June 21st \u2013 Wednesday, June 23rd, 2021. Raymond James Human Health Innovation Virtual ConferenceDate: Monday, June 21st\u00a0\u00a0Time: 12:00pm ET For those not attending the conference, a replay of the presentation will be available for 90 days in the &#8220;Events &amp; Presentations&#8221; section of OncoSec&#8217;s website at https:\/\/ir.oncosec.com\/events-presentations.\u00a0\u00a0 About OncoSec Medical IncorporatedOncoSec Medical Incorporated (the &#8220;Company,&#8221; &#8220;OncoSec,&#8221; &#8220;we&#8221; or &#8220;our&#8221;) is a biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body&#8217;s immune system to target and attack cancer. &hellip; Continue reading \"OncoSec to Present at the Raymond James Human Health Innovation Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/oncosec-to-present-at-the-raymond-james-human-health-innovation-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-05-27T12:34:17+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/686236\/oncosec_logo_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncosec-to-present-at-the-raymond-james-human-health-innovation-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncosec-to-present-at-the-raymond-james-human-health-innovation-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"OncoSec to Present at the Raymond James Human Health Innovation Conference","datePublished":"2021-05-27T12:34:17+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncosec-to-present-at-the-raymond-james-human-health-innovation-conference\/"},"wordCount":369,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncosec-to-present-at-the-raymond-james-human-health-innovation-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/686236\/oncosec_logo_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncosec-to-present-at-the-raymond-james-human-health-innovation-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/oncosec-to-present-at-the-raymond-james-human-health-innovation-conference\/","name":"OncoSec to Present at the Raymond James Human Health Innovation Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncosec-to-present-at-the-raymond-james-human-health-innovation-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncosec-to-present-at-the-raymond-james-human-health-innovation-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/686236\/oncosec_logo_Logo.jpg","datePublished":"2021-05-27T12:34:17+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncosec-to-present-at-the-raymond-james-human-health-innovation-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/oncosec-to-present-at-the-raymond-james-human-health-innovation-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncosec-to-present-at-the-raymond-james-human-health-innovation-conference\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/686236\/oncosec_logo_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/686236\/oncosec_logo_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncosec-to-present-at-the-raymond-james-human-health-innovation-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"OncoSec to Present at the Raymond James Human Health Innovation Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/499424","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=499424"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/499424\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=499424"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=499424"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=499424"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}